EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Risk of Adverse Systemic Events in Retinal Vein Occlusion

Emily A Albrecht, Priya Shukla, Alison H Zhao, Jonathan C Markle, Christopher M Maatouk, Rishi P Singh, Katherine E Talcott

Ophthalmology Retina · 2025

DOI: 10.1016/j.oret.2025.05.005 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2025. Verfasst von Emily A Albrecht und 6 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University School of Medicine, Cleveland, Ohio. Hauptthemen laut MEDLINE: Retinal Vein Occlusion, Myocardial Infarction. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Vein OcclusionMyocardial InfarctionHumansRetrospective StudiesMaleFemaleAgedRisk FactorsMiddle AgedAngiogenesis InhibitorsRisk AssessmentUnited StatesFollow-Up StudiesIntravitreal InjectionsIncidence

Stichwörter der Autor:innen

Branch retinal vein occlusion (BRVO)Central retinal vein occlusion (CRVO)Myocardial infarction (MI)StrokeTriNetX

Substanzen

Angiogenesis Inhibitors

Autor:innen und Institutionen

  • Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Case Western Reserve University School of Medicine, Cleveland, Ohio; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine, Case Western…
  • Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.
  • Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; Department of Internal Medicine, Boonshoft School of Medicine at Wright State University, Dayton, Ohio.
  • Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, Illinois.
  • Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio; Cole Eye Institute, Cleveland C…

Förderung

  • NEI NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • Research to Prevent Blindness

Zitieren

APA

Albrecht, E. A., Shukla, P., Zhao, A. H., Markle, J. C., Maatouk, C. M., Singh, R. P., & Talcott, K. E. (2025). Risk of Adverse Systemic Events in Retinal Vein Occlusion. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2025.05.005

Vancouver

Albrecht EA, Shukla P, Zhao AH, Markle JC, Maatouk CM, Singh RP, et al. Risk of Adverse Systemic Events in Retinal Vein Occlusion. Ophthalmology Retina. 2025. doi:10.1016/j.oret.2025.05.005

BibTeX
@article{Albrecht2025,
  author = {Albrecht, Emily A and Shukla, Priya and Zhao, Alison H and Markle, Jonathan C and Maatouk, Christopher M and Singh, Rishi P and Talcott, Katherine E},
  title = {Risk of Adverse Systemic Events in Retinal Vein Occlusion},
  journal = {Ophthalmology Retina},
  year = {2025},
  doi = {10.1016/j.oret.2025.05.005}
}
Kostenlos starten →